Swami Ramdev Rejects Patanjali Ghee Adulteration Claims, Says No Medicine Has Been Banned

Ramdev says Patanjali withdrew defamation case against Brij Bhushan Sharan Singh after clearing his "misconceptions"

September 24, 2026

Ramdev denies medicine ban, calls for changes to India's drug law

Company claims to have created five lakh jobs, with plans to add five lakh more in coming years

Yoga guru Swami Ramdev on Wednesday dismissed allegations of adulteration in Patanjali ghee and reports that some of the company’s medicines had been banned, telling a press conference in Delhi that those spreading such claims were behind a campaign of misinformation against the company.

Ramdev said the Supreme Court had not banned any Patanjali medicine and claimed the company’s products meet international standards, asserting that no agency in India or abroad had found any of its drugs to fall below required parameters. He also rejected allegations that Patanjali ghee was adulterated, saying the product could be tested at any laboratory.

Addressing the “animal fat” claims

Ramdev said several misconceptions about Patanjali had circulated over the past few months, including claims at different points that the company’s ghee contained animal fat or bone. Referring to earlier statements made by former MP Brij Bhushan Sharan Singh on the issue, Ramdev said Singh had spoken based on hearsay. He said he had since met Singh, that Singh’s misconceptions had been cleared, and that Patanjali had withdrawn the defamation case it had filed against him.

Calls for regulatory change

Ramdev also criticised India’s Drugs and Magic Remedies (Objectionable Advertisements) Act, calling it an outdated law that needs to be revised. He said Patanjali had raised this demand with the Prime Minister and would continue to press for changes.

Jobs claim and broader remarks

Speaking about the company’s reach, Ramdev said that as a monk he had taken yoga and Ayurveda to around 200 countries, and claimed Patanjali had created employment for roughly five lakh people, with plans to generate five lakh more jobs in the coming years. He said the company’s aim had been to give India’s ancient heritage a global identity by pairing it with science, and said he intended to keep building the company despite critics anticipating its decline.

Ramdev additionally said Patanjali was positioning itself against foreign companies and argued for a focus on equal opportunity rather than efforts to hold others back. He also made a claim challenging the World Health Organisation and India’s Ministry of Health, stating that Patanjali could treat a condition he referred to as “type-3 diabetes,” and said interested parties could approach the company directly. This claim has not been independently verified.

For all the latest updates, download PGurus App.